Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for REMEGEN?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2018–2025
Financial statements are reported in CNY, while share price and market cap are quoted in HKD.
Key Multi-Year Facts
- Revenue moved from CN¥11.3M in FY2018 to CN¥3.24B in FY2025 (7-year CAGR +124.4%).
- Net income was negative in FY2018, FY2019, FY2020, FY2022, FY2023, FY2024.
- Operating cash flow was below half of net income in FY2025.
Latest 5 Fiscal Years
| Fiscal Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (CNY B) | 1.42 | 0.77 | 1.08 | 1.71 | 3.24 |
| YoY | — | -46.1% | 40.2% | 58.9% | 89.5% |
| Net Income (CNY B) | 0.28 | -1.00 | -1.51 | -1.47 | 0.71 |
| YoY | — | -461.6% | — | — | — |
| Operating Cash Flow (CNY B) | 0.26 | -1.26 | -1.50 | -1.18 | 0.05 |
| ROE | 7.8% | -23.7% | -35.9% | -54.1% | 25.4% |
| Gross Margin | 95.3% | 64.8% | 76.5% | 80.0% | 86.9% |
| Net Margin | 19.4% | -130.1% | -140.4% | -85.9% | 21.9% |
| Debt-to-Assets | 17.1% | 17.3% | 37.8% | 63.9% | 50.2% |
Show all 8 fiscal years
| Fiscal Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue (CNY B) | 0.01 | — | 0.00 | 1.42 | 0.77 | 1.08 | 1.71 | 3.24 |
| YoY | — | — | — | — | -46.1% | 40.2% | 58.9% | 89.5% |
| Net Income (CNY B) | -0.27 | -0.43 | -0.70 | 0.28 | -1.00 | -1.51 | -1.47 | 0.71 |
| YoY | — | — | — | — | -461.6% | — | — | — |
| Operating Cash Flow (CNY B) | -0.13 | -0.28 | -0.66 | 0.26 | -1.26 | -1.50 | -1.18 | 0.05 |
| ROE | — | — | -19.4% | 7.8% | -23.7% | -35.9% | -54.1% | 25.4% |
| Gross Margin | 21.1% | — | — | 95.3% | 64.8% | 76.5% | 80.0% | 86.9% |
| Net Margin | -2384.5% | — | — | 19.4% | -130.1% | -140.4% | -85.9% | 21.9% |
| Debt-to-Assets | 193.8% | 133.7% | 12.7% | 17.1% | 17.3% | 37.8% | 63.9% | 50.2% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-05
Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).
Items Flagged for Review
-
Watch
Cash ConversionFinancial Quality
OCF / Net Income: FY2025 (2025-12-31) 0.07
FY2025 (ended 2025-12-31) · What is this?
-
Watch
Profit WarningMaterial Events
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
Dividends
No dividends paid over the trailing 12 months.
Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.
More data: All research reports · Sector leaders · Market hours & holidays.
Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.